Takahashi H, Cheng K M, Araki T
Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan.
Asia Oceania J Obstet Gynaecol. 1993 Jun;19(2):205-12. doi: 10.1111/j.1447-0756.1993.tb00374.x.
The effect of antenatal solcoseryl administration on hepatic glycogen synthesis and storage was studied in normal developing and intrauterine growth-retarded (IUGR) rat fetuses using biochemical analyses. The maximal effect of solcoseryl occurred 2 hours after administration. The glycogen content of the liver showed a significant increase in normal and IUGR fetuses with antenatal solcoseryl administration compared to their non-solcoseryl counterparts (p < 0.05). The activities of glycogen synthase enzymes, total and active forms, showed significant increases, at p < 0.05 and p < 0.005, respectively, in IUGR fetuses with antenatal solcoseryl administration. Active synthase also increased in normal fetuses with antenatal solcoseryl administration (p < 0.05). There were no significant changes in the activities of glycogen phosphorylase enzyme. These findings suggest that antenatal solcoseryl administration stimulates hepatic glycogen synthesis and storage in IUGR rat fetuses, and thus might favorably influence the development of neonatal hypoglycemia.
采用生化分析方法,研究了产前给予索高捷疗对正常发育和宫内生长受限(IUGR)大鼠胎儿肝脏糖原合成与储存的影响。索高捷疗的最大效应出现在给药后2小时。与未给予索高捷疗的胎儿相比,产前给予索高捷疗的正常和IUGR胎儿肝脏糖原含量显著增加(p<0.05)。产前给予索高捷疗的IUGR胎儿中,糖原合酶的总活性形式和活性形式的活性分别显著增加,p值分别<0.05和<0.005。产前给予索高捷疗的正常胎儿中活性合酶也增加(p<0.05)。糖原磷酸化酶的活性没有显著变化。这些发现表明,产前给予索高捷疗可刺激IUGR大鼠胎儿肝脏糖原的合成与储存,从而可能对新生儿低血糖的发展产生有利影响。